Mild overexpression of MeCP2 causes a progressive neurological disorder in mice

Human Molecular Genetics

Volumn 13, Issue 21, 2004, Pages 2679-2689

  Collins, Ann L ^a   Levenson, Jonathan M ^a   Vilaythong, Alexander P ^a   Richman, Ronald ^b   Armstrong, Dawna L ^a   Noebels, Jeffrey L ^a   Sweatt, J David ^a   Zoghbi, Huda Y ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYL CPG BINDING PROTEIN 2;

ANIMAL BEHAVIOR; ARTICLE; BEHAVIOR DISORDER; CONTROLLED STUDY; DATA ANALYSIS; DEATH; DISEASE COURSE; GENE DUPLICATION; GENE FUNCTION; GENE LOCUS; GENE MUTATION; GENE OVEREXPRESSION; GENETIC REGULATION; HIPPOCAMPUS; HUMAN; IN VIVO STUDY; LEARNING; MOLECULAR CLONING; MOTOR PERFORMANCE; MOUSE; NERVE CELL PLASTICITY; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROLOGIC DISEASE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; SEIZURE; TRANSGENIC MOUSE; WILD TYPE; X CHROMOSOME LINKED DISORDER;

ANIMALS; BEHAVIOR, ANIMAL; BLOTTING, WESTERN; CHROMOSOMAL PROTEINS, NON-HISTONE; DISEASE MODELS, ANIMAL; DNA-BINDING PROTEINS; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; IMMUNOHISTOCHEMISTRY; METHYL-CPG-BINDING PROTEIN 2; MICE; MICE, TRANSGENIC; MUTATION; NERVOUS SYSTEM DISEASES; REPRESSOR PROTEINS; RETT SYNDROME; TIME FACTORS; X CHROMOSOME;

MUS MUSCULUS;

EID: 8444253290     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/ddh282     Document Type: Article

References (54)

1. Hagberg, B., Aicardi, J., Dias, K. and Ramos, O. (1983) A progressive syndrome of autism, dementia, ataxia, and loss of purposeful hand use in girls: Rett's syndrome: report of 35 cases. Ann. Neurol. 14, 471-479.
2. Amir, R.E., Van den Veyver, I.B., Wan, M., Tran, C.Q., Francke, U. and Zoghbi, H.Y. (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat. Genet. 23, 185-188.
3. Amir, R.E., Van den Veyver, I.B., Schultz, R., Malicki, D.M., Tran, C.Q., Dahle, E.J., Philippi, A., Timar, L., Percy, A.K., Motil, K.J. et al. (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann. Neurol., 47, 670-679.
4. Bienvenu, T., Carrie, A., de Roux, N., Vinet, M.C., Jonveaux, P., Couvert, P., Villard, L., Arzimanoglou, A., Beldjord, C., Fontes, M. et al. (2000) MECP2 mutations account for most cases of typical forms of Rett syndrome. Hum. Mol. Genet., 9, 1377-1384.
5. Auranen, M., Vanhala, R., Vosman, M., Levander, M., Varilo, T., Hietala, M., Riikonen, R., Peltonen, L. and Jarvela, I. (2001) MECP2 gene analysis in classical Rett syndrome and in patients with Rett-like features. Neurology, 56, 611-617.
6. Bourdon, V., Philippe, C., Labrune, O., Amsallem, D., Arnould, C. and Jonveaux, P. (2001) A detailed analysis of the MECP2 gene: prevalence of recurrent mutations and gross DNA rearrangements in Rett syndrome patients. Hum. Genet., 108, 43-50.
7. Smeets, E., Schollen, E., Moog, U., Matthijs, G., Herbergs, J., Smeets, H., Curfs, L., Schrander-Stumpel, C. and Fryns, J.P. (2003) Rett syndrome in adolescent and adult females: clinical and molecular genetic findings. Am. J. Med. Genet., 122A, 227-233.
8. Hoffbuhr, K.C., Moses, L.M., Jerdonek, M.A., Naidu, S. and Hoffman, E.P. (2002) Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. Ment. Retard. Dev. Disabil. Res. Rev., 8, 99-105.
9. Laccone, F., Junemann, I., Whatley, S., Morgan, R., Butler, R., Huppke, P. and Ravine, D. (2004) Large deletions of the MECP2 gene detected by gene dosage analysis in patients with Rett syndrome. Hum. Mutat., 23, 234-244.
10. Amano K., Nomura, Y., Segawa, M. and Yamakawa, K. (2000) Mutational analysis of the MECP2 gene in Japanese patients with Rett syndrome. J. Hum. Genet., 45, 231-236.
11. Schollen, E., Smeets, E., Defiem, E., Fryns, J.P. and Matthijs, G. (2003) Gross rearrangements in the MECP2 gene in three patients with Rett syndrome: implications for routine diagnosis of Rett syndrome. Hum. Mutat., 22, 116-120.
12. Yusufzai, T.M. and Wolffe, A.P. (2000) Functional consequences of Rett syndrome mutations on human MeCP2. Nucl. Acids Res., 28, 4172-4179.
13. Ballestar, E., Yusufzai, T.M. and Wolffe, A.P. (2000) Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA. Biochemistry, 39, 7100-7106.
14. Couvert, P., Bienvenu, T., Aquaviva, C., Poirier, K., Moraine, C., Gendrot, C., Verloes, A., Andres, C., Le Fevre, A.C., Souville, I. et al. (2001) MECP2 is highly mutated in X-linked mental retardation. Hum. Mol. Genet., 10, 941-946.
15. Carney, R.M., Wolpert, C.M., Ravan, S.A., Shahbazian, M., Ashley-Koch, A., Cuccaro, M.L., Vance, J.M. and Pericak-Vance, M.A. (2003) Identification of MeCP2 mutations in a series of females with autistic disorder. Pediatr. Neurol., 28, 205-211.
16. Wan, M., Lee, S.S., Zhang, X., Houwink-Manville, I., Song, H.R., Amir, R.E., Budden, S., Naidu, S., Pereira, J.L., Lo, I.F. et al. (1999) Rett syndrome and beyond: recurrent spontaneous and familial MECP2 mutations at CpG hotspots. Am. J. Hum. Genet., 65 1520-1529.
17. Meloni, I., Bruttini, M., Longo, I., Mari, F., Rizzolio, F., D'Adamo, P., Denvriendt, K., Fryns, J.P., Toniolo, D. and Remeri, A. (2000) A mutation in the rett syndrome gene, MECP2, causes X-linked mental retardation and progressive spasticity in males. Am. J. Hum. Genet., 67, 982-985.
18. Kleefstra, T., Yntema, H.G., Oudakker, A.R., Romein, T., Sistermans, E., Nillessen, W., van Bokhoven, H., de Vries, B.B. and Hamel, B.C. (2002) De novo MECP2 frameshift mutation in a boy with moderate mental retardation, obesity and gynaecomastia. Clin. Genet. 61, 359-362.
19. Cohen, D., Lazar, G., Convert, P., Desportes, V., Lippe, D., Mazet, P. and Heron, D. (2002) MECP2 mutation in a boy with language disorder and schizophrenia. Am. J. Psychiatr., 159, 148-149.
20. Free, A., Wakefield, R.I., Smith, B.O., Dryden, D.T., Barlow, P.N. and Bird, A.P. (2000) DNA recognition by the methyl-CpG binding domain of MeCP2. J. Biol. Chem., 16, 16.
21. Nan, X., Ng, H.H., Johnson, C.A., Laherty, C.D., Turner, B.M., Eisenman, R.N. and Bird, A. (1998) Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature, 393, 386-389.
22. Jones, P.L., Veenstra, G.J., Wade, P.A., Vermaak, D., Kass, S.U., Landsberger, N., Strouboulis, J. and Wolffe, A.P. (1998) Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription. Nat. Genet., 19, 187-191.
23. Guy, J., Hendrich, B., Holmes, M., Martin, J.E. and Bird, A. (2001) A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome. Nat. Genet., 27, 322-326.
24. Chen, R.Z., Akbarian, S., Tudor, M. and Jaenisch, R. (2001) Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice. Nat. Genet., 27, 327-331.
25. Shahbazian, M., Young, J., Yuva-Paylor, L., Spencer, C., Antalffy, B., Noebels, J., Armstrong, D., Paylor, R. and Zoghbi, H. (2002) Mice with truncated MeCP2 recapitulate many Rett syndrome features and display hyperacetylation of histone H3. Neuron, 35, 243-254.
26. Nan, X., Campoy, F.J. and Bird, A. (1997) MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin. Cell, 88, 471-481.
27. Rietveld, L.E., Caldenhoven, E. and Stunnenberg, H.G. (2002) In vivo repression of an erythroid-specific gene by distinct corepressor complexes. EMBO J., 21, 1389-1397.
28. Chen, W.G., Chang, Q., Lin, Y., Meissner, A., West, A.E., Griffith, E.C., Jaenisch, R. and Greenberg, M.E. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science, 302, 885-889.
29. El-Osta, A., Kantharidis, P., Zalcberg, J.R. and Wolffe, A.P. (2002) Precipitous release of methyl-CpG binding protein 2 and histone deacetylase 1 from the methylated human multidrug resistance gene (MDR1) on activation. Mol. Cell. Biol., 22, 1844-1857.
30. Lin, X. and Nelson, W.G. (2003) Methyl-CpG-binding domain protein-2 mediates transcriptional repression associated with hypermethylated GSTP1 CpG islands in MCF-7 breast cancer cells. Cancer Res., 63, 498-504.
31. Tudor, M., Akbarian, S., Chen, R.Z. and Jaenisch, R. (2002) Transcriptional profiling of a mouse model for Rett syndrome reveals subtle transcriptional changes in the brain. Proc. Natl Acad. Sci. USA., 99, 15536-15541.
32. Martinowich, K., Hattori, D., Wu, H., Fouse, S., He, F., Hu, Y., Fan, G. and Sun, Y.E. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302, 890-893.
33. Yu, F., Thiesen, J. and Stratling, W.H. (2000) Histone deacetylase-independent transcriptional repression by methyl-CpG-binding protein 2. Nucl. Acids Res., 28, 2201-2206.
34. Kimura, H. and Shiota, K. (2003) Methyl-CpG-binding protein, MeCP2, is a target molecule for maintenance DNA methyltransferase, Dnmt1. J. Biol. Chem., 278, 4806-4812.
35. Fuks, F., Hurd, P.J., Wolf, D., Nan, X., Bird, A.P. and Kouzarides, T. (2003) The methyl-CpG-binding protein MeCP2 links DNA methylation to histone methylation. J. Biol. Chem., 278, 4035-4040.
36. Georgel, P.T., Horowitz-Scherer, R.A., Adkins, N., Woodcock, C.L., Wade, P.A. and Hansen, J.C. (2003) Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation. J. Biol. Chem., 278, 32181-32188.
37. Buschdorf, J.P. and Stratling, W.H. (2004) A WW domain binding region in methyl-CpG-binding protein MeCP2: impact on Rett syndrome. J. Mol. Med., 82, 135-143.
38. Luikenhuis, S., Giacometti, E., Beard, C.F. and Jaenisch, R. (2004) Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice. Proc. Natl Acad. Sci. USA, 101, 6033-6038.
39. Kriaucionis, S. and Bird, A. (2004) The major form of MeCP2 has a novel N-terminus generated by alternative splicing. Nucl. Acids Res., 32, 1818-1823.
40. Mnatzakanian, G.N., Lohi, H., Munteanu, I., Alfred, S.E., Yamada, T., MacLeod, P.J., Jones, J.R., Scherer, S.W., Schanen, N.C., Friez, M.J. et al. (2004) A previously unidentified MECP2 open reading frame defines a new protein isoform, relevant to Rett syndrome. Nat. Genet., 36, 339-341.
41. Schedl, A., Beermann, F., Thies, E., Montoliu, L., Kelsey, G. and Schutz, G. (1992) Transgenic mice generated by pronuclear injection of a yeast artificial chromosome. Nucl. Acids Res., 20, 3073-3077.
42. Montoliu, L., Schedl, A., Kelsey, G., Zentgraf, H., Lichter, P. and Schutz, G. (1994) Germ line transmission of yeast artificial chromosomes in transgenic mice. Reprod. Fertil. Dev., 6, 577-584.
43. Heintz, N. (2000) Analysis of mammalian central nervous system gene expression and function using bacterial artificial chromosome-mediated transgenesis. Hum. Mol. Genet., 9, 937-943.
44. Reichwald, K., Thiesen, J., Wiehe, T., Weitzel, J., Poustka, W.A., Rosenthal, A., Platzer, M., Stratling, W.H. and Kioschis, P. (2000) Comparative sequence analysis of the MECP2-locus in human and mouse reveals new transcribed regions. Mamm. Genome, 11, 182-190.
45. Balmer, D., Goldstine, J., Rao, Y.M. and LaSalle, J.M. (2003) Elevated methyl-CpG-binding protein 2 expression is acquired during postnatal human brain development and is correlated with alternative polyadenylation. J. Mol. Med., 81, 61-68.
46. Coy, J.F., Sedlacek, Z., Bachner, D., Delius, H. and Poustka, A. (1999) A complex pattern of evolutionary conservation and alternative polyadenylation within the long 3′-untranslated region of the methyl-CpG-binding protein 2 gene (MeCP2) suggests a regulatory role in gene expression. Hum. Mol. Genet., 8, 1253-1262.
47. Shahbazian, M.D., Antalffy, B., Armstrong, D.L. and Zoghbi, H.Y. (2002) Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation. Hum. Mol. Genet., 11, 115-124.
48. Gerlai, R. (1998) Contextual learning and cue association in fear conditioning in mice: a strain comparison and a lesion study. Behav. Brain Res., 95, 191-203.
49. Blanchard, D.C. and Blanchard, R.J. (1972) Innate and conditioned reactions to threat in rats with amygdaloid lesions. J. Comp. Physiol. Psychol., 81, 281-290.
50. Hess, G., Kuhnt, U. and Voronin, L.L. (1987) Quantal analysis of paired-pulse facilitation in guinea pig hippocampal slices. Neurosci. Lett., 77, 187-192.
51. Ariani, F., Mari, F., Pescucci, C., Longo, I., Bruttini, M., Meloni, I., Hayek, G., Rocchi, R., Zappella, M. and Renieri, A. (2004) Real-time quantitative PCR as a routine method for screening large rearrangements in Rett syndrome: report of one case of MECP2 deletion and one case of MECP2 duplication. Hum. Mutat., 24, 172-177.
52. Samaco, R.C., Nagarajan, R.P., Braunschweig, D. and LaSalle, J.M. (2004) Multiple pathways regulate MeCP2 expression in normal brain development and exhibit defects in autism-spectrum disorders. Hum. Mol. Genet., 13, 629-639.
53. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227, 680-685.
54. Qiao, X. and Noebels, J.L. (1993) Developmental analysis of hippocampal mossy fiber outgrowth in a mutant mouse with inherited spike-wave seizures. J. Neurosci., 13, 4622-4635.